1. Home
  2. HYFT

as of 03-10-2026 3:39pm EST

$1.31
+$0.21
+19.72%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Founded: 1983 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 69.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 312.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $1.05 - $3.00 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): -29.33% Revenue Growth (next year): 51.71%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Latest MindWalk Holdings Corp. News

HYFT Breaking Stock News: Dive into HYFT Ticker-Specific Updates for Smart Investing

All HYFT News

Share on Social Networks: